Detalhe da pesquisa
1.
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA).
Anticancer Drugs
; 30(4): 394-401, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30875348
2.
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.
Lancet Oncol
; 13(2): 135-44, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22257523
3.
A three-year data set of gaseous field emissions from crop sequence at three sites in Germany.
Sci Data
; 9(1): 415, 2022 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842434
4.
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
Breast Cancer Res Treat
; 128(2): 457-66, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21607586
5.
Prevention of intraprocedural puncture site bleeding during arterial port implantation by use of a suture-mediated arterial closure system: a prospective randomized trial.
J Vasc Interv Radiol
; 22(10): 1409-13, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21514842
6.
APC promoter hypermethylation is an early event in endometrial tumorigenesis.
Cancer Sci
; 101(2): 321-7, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900189
7.
Role of GPR30 in endometrial pathology after tamoxifen for breast cancer.
Am J Obstet Gynecol
; 203(6): 595.e9-16, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20965484
8.
Interval between port catheter flushing can be extended to four months.
Gynecol Obstet Invest
; 70(2): 91-4, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20224280
9.
The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors.
Semin Oncol
; 36(4 Suppl 2): S55-68, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19660684
10.
P16 alterations increase the metastatic potential of endometrial carcinoma.
Gynecol Oncol
; 111(2): 365-71, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18790522
11.
Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Am J Obstet Gynecol
; 199(5): e6-8, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18984073
12.
Checkpoint Inhibitors in Breast Cancer - Current Status and Future Directions.
Breast Care (Basel)
; 13(1): 27-31, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29950964
13.
Ovarian cyst torsion and extreme ovarian stimulation in a premenopausal patient treated with tamoxifen for ductal carcinoma in situ of the breast.
Am J Obstet Gynecol
; 195(4): e5-6, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17000228
14.
Adjuvant therapy for early breast cancer.
N Engl J Med
; 356(12): 1268-9, 2007 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-17377168
15.
Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
Recent Results Cancer Res
; 162: 135-40, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12790327
16.
A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women.
Cancer Treat Rev
; 39(5): 457-65, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22840697
17.
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.
J Cancer Res Clin Oncol
; 139(12): 2047-56, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072232
18.
Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel Discussion.
Breast Care (Basel)
; 7(2): 137-143, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22740801
19.
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study.
J Clin Oncol
; 30(21): 2585-92, 2012 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22689807
20.
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
J Clin Oncol
; 30(9): 921-9, 2012 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22331954